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Synopsis 
Transition metal bis(thiosemicarbazone) complexes have been of great interest in the last five 
decades. One of the most striking features of these complexes is that they possess a wide 
range of biological properties including antimalarial, antibacterial and anticancer activity. 
Zinc and copper bis(thiosemicarbazone) complexes have recently attracted attention due to 
their intracellular fluorescence and anticancer activity, respectively. The present work 
“Targeting Cancer Cells and Live Cell Imaging Using Bis(thiosemicarbazone) Complexes of 
Copper and Zinc” is an effort to target cancer cells using folic acid or biotin linked anticancer 
active copper bis(thiosemicarbazone) complexes. Interestingly, bis(thiosemicarbazone) 
ligands form zinc complexes that could be used to image cancer cells and one of the ligands 
could be used for imaging zinc in the cells. 
Chapter 1, provides a brief introduction to metal complexes in medicine. Different 
classes of metallodrugs and their mechanism of action are listed. A short discussion on 
different types of diagnostic drugs and transition metal complexes possessing anticancer 
activity is presented. An overview of the strategies available to target cancer cells is included. 
Furthermore, the use of thiosemicarbazone compounds for anticancer activity is reviewed in 
detail. Recent examples of bis(thiosemicarbazone) compounds in medicinal studies is briefly 
mentioned. This section ends with the scope of the present work which involves 
bis(thiosemicarbazone) complexes of zinc and copper.  
Chapter 2, “Zinc bis(thiosemicarbazone) complexes for live cell imaging and 
anticancer activity” deals with the synthesis and characterization of a series of mononuclear 
and binuclear zinc bis(thiosemicarbazone) complexes by varying substituents at the diketone 
moiety or at the thiosemicarbazide fragment of the ligand. The crystal structures of 
mononuclear ligand benzil-bis(4-pyrrolidine-3-thiosemicarbazone) (BTSCH2), zinc glyoxal-
bis(4-methyl-4-phenyl-3-thiosemicarbazone) [Zn(GTSC)]3 and [Zn(BTSC)(DMSO)] 
complexes were determined using single-crystal X-ray crystallography. Here, the 
mononuclear zinc complexes were utilized as live cell imaging agents whereas binuclear zinc 
complexes proved to be anticancer agents. Among the many mononuclear complexes 
prepared, the trimeric zinc complex derived from glyoxal- bis(4-methyl-4-phenyl-3-
thiosemicarbazone) was found to be the most fluorescent complex owing to its unique 
structure. This permitted live cell imaging in a number of cancer cell lines. In comparison 
with the well studied zinc biacetyl-bis(4-methyl-3-thiosemicarbazone) Zn(ATSM) complex, 
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which was used as a reference, [Zn(GTSC)]3 had a 2.5 fold higher fluorescence quantum 
yield in DMSO. The cellular fluorescence was measured in collaboration with Prof. 
K.Somasundaram’s laboratory at MCBL using flow cytometry. It was observed that 
[Zn(GTSC)]3 had 3 to 12 fold higher fluorescence than Zn(ATSM) in various cell lines (n = 
9) of different tissue origin. Confocal fluorescence microscopy studies established that 
[Zn(GTSC)]3 localizes in the nucleus of human breast cancer MCF-7 and MDA-MB-231 
cells within 30 minutes of addition. Moreover, [Zn(GTSC)]3 showed relatively less 
cytotoxicity compared to the Zn(ATSM) complex in all the cancer cell lines tested. DNA 
interaction studies such as binding and cleavage showed that [Zn(GTSC)]3  was less harmful 
to DNA as well. All these features make [Zn(GTSC)]3 a good fluorescent imaging agent for 
live cells. Binuclear zinc bis(thiosemicarbazone) complexes were also synthesized and their 
cytotoxicity was evaluated in  different cancer cells. One of the ligands, 1,3-bis{biacetyl-2′-
(4"-N-pyrrolidinethiosemicarbazide)-3′-(4"-N-thiosemicarbazide)} propane (ProBATpyrH4), 
and its zinc complex were found to show excellent anticancer activity against human 
hepatocellular cancer (HepG2) cell line. However, the cellular uptake studies as followed by 
flow cytometry revealed that these compounds do not fluoresce inside the cells. However, the 
DNA interaction studies using ethidium bromide displacement assay revealed that these 
complexes have better binding ability to DNA than mononuclear zinc complexes and the 
viscometric titrations suggested the binding mode to DNA is through partial intercalation. 
Apparently, these complexes do not induce DNA cleavage as evident from the cleavage 
experiments performed on pBR322 DNA. It is likely that their anticancer activity is due to 
unique DNA binding properties. 
Imaging zinc is important in the field of metallomics as alteration of zinc 
concentration in cells is associated with, or attributed to various diseases. In this regard, 
bis(thiosemicarbazone) ligands are useful. Chapter 3, “Imaging intracellular zinc using 
glyoxal-bis(4-methyl-4-phenyl-3-thiosemicarbazone) ligand”  deals with imaging zinc in live 
cells using the bis(thiosemicarbazone) ligand, GTSCH2. Since the trimeric zinc complex is 
fluorescent, the corresponding ligand, GTSCH2, was utilized to visualize the zinc present 
within cells. The ligand GTSCH2 is found to be a selective fluorescence “turn-on” sensor for 
zinc. This sensor exhibited excellent sensitivity and selectivity towards zinc over other 
physiologically relevant cations. The binding affinity of GTSCH2 to zinc was estimated to be 
0.59 nM in an aqueous MOPS (50 mM, NaCl; 100 mM; pH 7.3) buffer containing 30% 
DMSO, from competitive binding experiments carried out with ethylene glycol tetraacetic 
acid (EGTA). The sensor displayed maximal fluorescence response to zinc ion when present 
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in the ratio of 1:1 and displayed stable fluoresence in the pH range 5.0 to 7.8, which suggests 
that the probe may be suitable for imaging zinc in both normal and cancer cells. The potential 
of GTSCH2 to image zinc inside the cell has been demonstrated in two human breast cancer 
cell lines using confocal fluorescence microscopy. 
Unlike mononuclear zinc complexes, the mononuclear copper bis(thiosemicarbazone) 
complexes are cytotoxic. Chapter 4, “Anticancer activity of copper bis(thiosemicarbazone) 
complexes” deals with the synthesis, characterization and anticancer activity of mononuclear 
copper bis(thiosemicarbazone) complexes. All of them were characterized by spectroscopic 
methods and in three cases by single crystal X-ray diffraction. The redox properties, studied 
by cyclic voltammetry, showed reversible one electron- reduction process that varied from –
0.53 V to –0.18 V vs SCE. Anticancer activity for the synthesized complexes and their 
ligands were tested against many human cancer cell lines where the complexes Cu(GTSC) 
and Cu(GTSCHCl) derived from glyoxal-bis(4-methyl-4-phenyl-3-thiosemicarbazone) are 
found to be most cytotoxic (GI50 <0.1 µM to 2.1 µM) in five cancer cell lines tested. 
Moreover, the cytotoxicity is similar to that of adriamycin, a known anticancer drug, in all 
cell lines. However, it is less potent than a copper bis(thiosemicarbazone) analog, copper 
biacetyl-bis(4-methyl-3-thiosemicarbazone) Cu(ATSM), a well studied anticancer agent in 
many cell lines. Cellular studies were carried out for the selected complexes Cu(GTSC) and 
Cu(GTSCHCl) along with Cu(ATSM) on HCT116 colon cancer cells. The order of 
lipophilicity and cellular uptake as studied by ICP-OES are correlated with their cytotoxicity. 
Based on the interaction of these complexes with DNA using the ethidium bromide 
displacement assay, DNA -melting, -viscosity and -cleavage studies, it is suggested that these 
complexes intercalate partially with DNA. DNA cleavage studies using pBR322 DNA 
revealed that only Cu(GTSCHCl) complex cleaves DNA. Mechanistic discrimination studies 
suggest that the complex cleaves DNA through the hydrolytic pathway. Since the 
topoisomerase IIα (Topo IIα), a nuclear enzyme resolving topological problems of DNA, is 
considered as one of the possible molecular targets for a number of anticancer drugs 
including some of the copper thiosemicarbazone complexes, Topo IIα inhibition studies were 
carried out in human Topo IIα. Interestingly, many copper bis(thiosemicarbazone) complexes 
are able to inhibit Topo IIα activity by acting as Topo IIα poison. Cu(GTSCHCl) complex 
was found to be the most active in this series of complexes (90 % inhibition at 100 µM) and it 
inhibits the enzyme in a dose dependant manner. Based on the results, it was concluded that 
the cell death may be mediated, at least in part, through DNA cleavage and Topo IIα 
inhibition. 
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Severe side effects, poor distribution profiles and or organ specific toxicity make the 
conventional chemotherapy of limited value with metal based drugs. Therefore, developing 
cancer-specific drug delivery systems is an urgent need in cancer therapy. Among the many 
strategies available to target cancer, targeting the receptors that are overexpressed in the 
cancer cell membrane is a novel strategy being used in recent studies. Therefore the last part 
my work, “Copper bis(thiosemicarbazone) complexes linked to poly(ethylene glycol) and 
multiwalled carbon nanotubes for targeted delivery to cancer cells ” was designed to target 
cancer cells. Here, copper complexes (therapeutic molecule) were attached with PEG and 
MWCNT (carrier) along with folic acid or biotin (targeting molecule). First, CuATSM–A 
was functionalized with a disulfide linker and connected with folic acid via a poly(ethylene 
glycol) (PEG600) linker. This was synthesized to target KB (human nasopharyngeal 
carcinoma) cells, a cell line that overexpresses the folate receptor on the cell surface. In order 
to investigate the targeting efficacy, the corresponding fluorescent labeled analogs and non-
targeted PEG conjugates were synthesized. Flow cytometry studies with fluorescent marker 
(fluorescein isothiocyanate) labeled PEG analogs showed the targeting efficacy on KB cells. 
The copper complex, CuATSM–A, attached with biotin–PEG2000 also was synthesized to 
target high-biotin-using HeLa (human cervical carcinoma) cells. Multiwalled carbon 
nanotubes (MWCNT) were also used as nanocarriers. Here, the MWCNT was decorated with 
PEG600 diamine and then functionalized with the copper complex (therapeutic molecule), 
folic acid (targeting molecule), and FITC (fluorescent molecule).  The conjugation of all the 
molecules with MWCNT is characterized by various spectroscopic techniques. 
 
 
